Digital therapeutics at a turning point: What we heard at DTx East

This year the digital therapeutics space took a hit with the downfall of Pear Therapeutics, one of the most well-known of the industry’s still-active pioneers. Combined with Akili Interactive’s hard pivot to OTC, some in the industry are wondering whether standalone prescription digital therapeutics are a failed experiment.

Digital therapeutics at a turning point: What we heard at DTx East | pharmaphorum